These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 6130293

  • 1. Prognosis after immunosuppression of patients with crescentic nephritis requiring dialysis.
    Hind CR, Paraskevakou H, Lockwood CM, Evans DJ, Peters DK, Rees AJ.
    Lancet; 1983 Feb 05; 1(8319):263-5. PubMed ID: 6130293
    [Abstract] [Full Text] [Related]

  • 2. Plasma exchange and immunosuppressive drugs in the treatment of glomerulonephritis due to antibodies to the glomerular basement membrane.
    Pusey CD, Lockwood CM, Peters DK.
    Int J Artif Organs; 1983 Jul 05; 6 Suppl 1():15-8. PubMed ID: 6642729
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Crescentic glomerulonephritis without immune deposits: clinicopathologic features.
    Stilmant MM, Bolton WK, Sturgill BC, Schmitt GW, Couser WG.
    Kidney Int; 1979 Feb 05; 15(2):184-95. PubMed ID: 390211
    [Abstract] [Full Text] [Related]

  • 8. [Anti-basement-membrane antibody mediated, rapidly progressive, glomerulonephritis. Diagnostic and therapeutic strategy based on a retrospective study of 14 cases].
    Bouget J, Le Pogamp P, Perrier G, Ramée MP, Rivalan J, Camus C, Thomas R, Chevet D.
    Ann Med Interne (Paris); 1990 Feb 05; 141(5):409-15. PubMed ID: 2256583
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Relapse in anti glomerular basement membrane antibody mediated crescentic glomerulonephritis.
    Wu MJ, Moorthy AV, Beirne GJ.
    Clin Nephrol; 1980 Feb 05; 13(2):97-102. PubMed ID: 7363520
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antiglomerular basement membrane antibody mediated disease in the British Isles 1980-4.
    Savage CO, Pusey CD, Bowman C, Rees AJ, Lockwood CM.
    Br Med J (Clin Res Ed); 1986 Feb 01; 292(6516):301-4. PubMed ID: 3080145
    [Abstract] [Full Text] [Related]

  • 16. Treatment and prognosis in antibasement membrane antibody-mediated nephritis.
    Peters DK, Rees AJ, Lockwood CM, Pusey CD.
    Transplant Proc; 1982 Sep 01; 14(3):513-21. PubMed ID: 7179435
    [No Abstract] [Full Text] [Related]

  • 17. Intensive plasma exchange in crescentic glomerulonephritis: help or no help?
    Glassock RJ.
    Am J Kidney Dis; 1992 Sep 01; 20(3):270-5. PubMed ID: 1519608
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical and morphological aspects of the management of crescentic anti-glomerular basement membrane antibody (anti-GBM) nephritis/Goodpasture's syndrome.
    Walker RG, Scheinkestel C, Becker GJ, Owen JE, Dowling JP, Kincaid-Smith P.
    Q J Med; 1985 Jan 01; 54(213):75-89. PubMed ID: 3975346
    [Abstract] [Full Text] [Related]

  • 20. Coexistent anti-neutrophil cytoplasmic antibody and antiglomerular basement membrane antibody associated disease = report of six cases.
    Bonsib SM, Goeken JA, Kemp JD, Chandran P, Shadur C, Wilson L.
    Mod Pathol; 1993 Sep 01; 6(5):526-30. PubMed ID: 8248108
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.